Consolidated cash flow statements

Consolidated cash flow statements

(unaudited)

 

Three months ended 31 March

(thousands of €)

2016

2015

Cash and cash equivalents at beginning of year

340,314

187,712

 

 

 

Net income / loss (–)

35,950

(14,227)

 

 

 

Adjustments for:

 

 

Tax income (–) / expenses

(1,468)

Other net financial expense

4,134

364

Fair value re-measurement of Share Subscription Agreement

(57,479)

Depreciation of property, plant and equipment

755

476

Amortization of intangible fixed assets

209

232

Net realized loss on foreign exchange transactions

(724)

(41)

Share-based compensation

1,902

492

Increase in pension liabilities

61

73

Gain on sale of fixed assets

(13)

 

 

 

Operating cash flows before movements in working capital

(15,206)

(14,099)

 

 

 

Increase in inventories

(23)

(31)

Increase in receivables

(5,209)

(4,116)

Increase / decrease (–) in payables

928

(2,114)

Increase / decrease (–) in deferred income

270,926

(12,584)

 

 

 

Cash generated / used (–) in operations

251,416

(32,944)

 

 

 

Interest paid

(13)

(15)

Interest received

144

228

 

 

 

Net cash flows generated / used (–) in operating activities

251,547

(32,731)

 

 

 

Purchase of property, plant and equipment

(1,024)

(432)

Purchase of and expenditure in intangible fixed assets

(41)

(45)

Proceeds from disposal of property, plant and equipment

16

43

Proceeds from disposal of intangible fixed assets

182

Decrease in restricted cash

568

 

 

 

Net cash flows generated / used (–) in investing activities

(1,050)

316

 

 

 

Repayment of obligations under finance leases and other debts

(17)

(5)

Proceeds from capital and share premium increases, net of issue costs

392,044

Proceeds from capital and share premium increases from exercise of warrants

5,819

 

 

 

Net cash flows generated in financing activities

392,027

5,814

 

 

 

Effect of exchange rate differences on cash and cash equivalents

(4,505)

151

 

 

 

Increase / decrease (–) in cash and cash equivalents

638,020

(26,450)

 

 

 

Cash and cash equivalents at end of reporting period

978,334

161,262